Search

ABSTRACT: Chronic pleuritis is the main reason for sending pig carcasses to the Department of Final Inspection (DIF), condemnation and led to economic losses to industries and producers. Most pleura lesions detected after slaughter are sequelae from bacterial infections by agents that do not pose risks to pork consumers. The objective of the present study was to generate science-based information for decision making in the evaluation and destination of chronic pleuritis by the Federal Inspection Service (SIF). Therefore, 200 carcasses, with and without pleurisy, from a swine slaughterhouse with SIF were assessed following the visual classification of the inspection agent. The study was carried out in two stages. In stage 1, 50 carcasses with pneumonic lesions adjacent to chronic pleuritis and 50 carcasses with only chronic pleuritis lesions were evaluated, through macroscopy, histopathology, and bacterial culture. In stage 2, 50 swine carcasses with chronic pleuritis and 50 without this lesion were sampled in the parietal pleura region to bacterial culture and PCR. The economic impact of not exporting these carcasses with chronic pleuritis was also assessed. Considering the stages of evolution of the lesions, the macroscopic examination showed high correlation with the histological examination. There was no bacterial isolation through pleural swabs, regardless of the presence or not of adjacent pulmonary lesions. Isolation was restricted to the adjacent pulmonary lesions of 70% samples, with Pasteurella multocida type A found in 48% of them, followed by P. multocida type D and Streptococcus suis in 12%, and Actinobacillus pleuropneumoniae in 3%. Only Streptococcus suis DNA was detected in 5/100 samples, with no correspondence to the isolation of viable bacteria. The reliability demonstrated in the macroscopic evaluation carried out during inspection, the absence of viable bacteria in the chronic pleural lesions, and the negative economic impact suggest that carcasses with chronic pleuritis can be submitted to pleura removal, with no need of sending to DIF.

The serum neutralization (SN) test is the gold standard method to measure neutralizing antibodies to bovine herpesviruses. However, in view of the further subdivisions of bovine herpesviruses in types/subtypes, defining which virus to use at challenge in SN tests may be difficult. In view of that, this study was carried out to re-evaluate (SN) sensitivity with different types/subtypes of bovine herpesviruses types 1 (BoHV-1) and 5 (BoHV-5) as challenge viruses. Bovine sera (n=810) were collected from two distinct geographic regions and tested by SN with three type 1 viruses (BoHV-1.1 strains "Los Angeles" and "EVI123/98"; BoHV-1.2a strain "SV265/96") and three type 5 viruses (BoHV-5a strain "EVI88/95"; BoHV-5b strain "A663" and BoHV-5c "ISO97/95"). SN tests were performed with a 1 hour incubation of the serum-virus mixtures at 37ºC against 100 TCID50 of each of the viruses. SN sensitivity varied greatly depending on the challenge virus used in the test. The highest sensitivity (327 positive/810 total sera tested; 40.37%) was attained when the positive results to the six viruses were added together. No association could be found between any particular type or subtype of virus and the sensitivity of the test. When positive results to each single strain were considered, SN sensitivity varied from 41.7% to 81.7%, depending on the virus and the geographic region of origin of the sera. Variation was detected even when challenge viruses belonged to the same subtype, where disagreement between positive results reached 41%. These results indicate that one hour incubation SN tests against single viruses, as performed here, may display a significantly low sensitivity (p=0.05); performing SN tests against a number of different viruses may increase considerably SN sensitivity. Furthermore, the choice of virus used for challenge is critical in SN tests. In addition, sera from different geographic regions may give rise to disagreeing results with different strains of BoHV-1 and BoHV-5. This might be particularly relevant for control programs and in international trade, were maximum sensitivity should be targeted.O teste de soroneutralização (SN) é o método padrão para a mensuração de anticorpos neutralizantes para herpesvírus bovinos. Entretanto, com as subdivisões propostas destes agentes em tipos e subtipos, a definição de qual amostra utilizar como virus de desafio à SN pode ser difícil. Em vista disso, este estudo foi realizado para re-avaliar a sensibilidade de testes de SN utilizando diferentes tipos e subtipos de herpesvírus bovinos tipos 1 (BoHV-1) e 5 (BoHV-5) como amostras de desafio. Soros bovinos (n=810) foram coletados de duas regiões geográficas distintas e testados frente a amostras do tipo 1 (BoHV-1.1: amostras "Los Angeles" e "EVI123/98", BoHV-1.2a: amostra "SV265/96") e três amostras do tipo 5 (BoHV-5a: "EVI88/95"; BoHV-5b: "A663" e BoHV-5c "ISO97/95"). Os testes de SN foram realizados com incubação de 1 hora a 37ºC da mistura soro-vírus, frente a 100 doses infectantes para 50% dos cultivos celulares (DICC50) de cada um dos vírus. A sensibilidade da SN variou grandemente em função do vírus utilizado no teste. A maior sensibilidade (327 soros positivos/810 soros testados; 40.37%) foi alcançada quando os resultados positivos frente aos seis diferentes vírus foram somados. Nenhuma associação foi detectada entre determinado tipo/subtipo de vírus e a sensibilidade do teste. Quando resultados positivos frente a cada vírus foram considerados isoladamente, a sensibilidade da SN variou entre 41,7% a 81,7%, dependendo do vírus de desafio e da região geográfica de origem das amostras de soro. Variação foi detectada mesmo quando as amostras de desafio pertenciam a um mesmo subtipo; a discrepância entre os resultados positivos atingiu até 41%. Estes resultados indicam que testes de SN contra amostras isoladas de vírus podem apresentar uma sensibilidade notadamente baixa; o emprego de diferentes amostras de vírus de desafio pode aumentar consideravelmente a sensibilidade da prova. Além disso, a escolha da amostra de vírus para a realização do teste é crítica. Outro achado importante é que sorors de diferentes regiões geográficas podem dar resultados discordantes frente a diferentes amostras de BoHV-1 e BoHV-5. Estes achados são particularmente relevantes para programas de controle destas infecções e para o comércio internacional, onde a sensibilidade deve ser maximizada.

São apresentados os resultados de 23 anos de diagnósticos de raiva realizados no Instituto de Pesquisas Veterinárias Desidério Finamor, no Estado do Rio Grande do Sul, Brasil. Entre os anos de 1985 e 2007, um total de 23.460 amostras foram diagnosticadas no laboratório, compreendendo cerca de 95% do número total de amostras submetidas ao diagnóstico laboratorial de raiva no Estado. A metodologia utilizada seguiu técnicas padrões como a imunofluorescência direta (IFD) e inoculação em camundongos (IC). Não ocorreram casos de raiva humana no período. O vírus rábico (VR) foi detectado em 739 (3,1%) amostras, sendo 656 (88,7%) de origem bovina. O vírus foi também identificado em 23 caninos (3,1%), 21 eqüinos (2,9%), 29 quirópteros (4,0%), 4 felinos (0,5%), 3 ovinos (0,4%), 2 suínos (0,27%) e em um animal selvagem de espécie indeterminada (0,13%). O último caso de raiva em cães associado com variantes do vírus endêmicas nessa espécie foi diagnosticado em 1988. Dois episódios de contaminação incidental registrados em um felino em 2001 e em um canino em 2007, associados com variantes do vírus prevalentes em morcegos. Em relação à raiva bovina, os dados aqui apresentados revelam uma marcante diminuição no número de casos de raiva nessa espécie, em comparação com registros prévios. Por outro lado, um aumento no número de casos de raiva em morcegos hematófagos e não hematófagos vem sendo observado; no entanto, não é possível associar este aumento com modificações nas relações vírus/hospedeiro, pois o número de morcegos submetidos para diagnóstico tem igualmente aumentado. Isto provavelmente reflete o aumento do conhecimento sobre o papel de morcegos no ciclo de transmissão, e não necessariamente alterações no vírus e/ou nos hospedeiros.The results of 23 years of rabies diagnosis carried out at the Veterinary Research Institute Desidério Finamor, in the state of Rio Grande do Sul, RS, Brazil, are reported. From 1985 to 2007, a total of 23.460 specimens were examined, corresponding to 95% of the total number of samples submitted to rabies laboratory diagnosis notified within the state. Diagnostic methods included standard techniques such as the fluorescent antibody test (FAT) and mouse inoculation test (MIT). No cases of human rabies occurred in the period. Rabies virus (RV) was detected in 739 specimens (3.1%), from which 656 (88.7%) were from cattle. The virus was also identified in specimens from 23 dogs (3.1%), 21 horses (2.9%), 29 bats (4.0%), 4 cats (0.5%), 3 sheep (0.4%), 2 pigs (0.27%) and a wild animal of undetermined species (0.13%). The last case of rabies associated with a canine variant was diagnosed in 1988. Two cases of rabies associated with bat variant viruses were reported, in a domestic cat (2001) and in a dog (2007). In cattle, a marked tendency to a decrease in the number of cases was detected in the examined period. In contrast, an increase in the number of cases in haematophagous as well as in non haematophagous bats is noticed. However, as the number of bat specimens submitted for diagnosis has increased, this finding most likely reflects a higher degree of awareness on the possible role for bats in the rabies transmission cycle, rather than any particular changes on the virus or its hosts.

No presente estudo, foi realizada uma pesquisa em busca de anticorpos neutralizantes contra os vírus da cinomose (CDV) e da parainfluenza (CPIV) caninos em amostras de soro de 173 cães recolhidos a canis municipais em Novo Hamburgo (n=82) e Porto Alegre (n=91), RS. A pesquisa de anticorpos neutralizantes foi realizada pela técnica de soroneutralização frente a duas amostras vacinais de CDV (Rockborn e Snyder Hill) e frente a uma amostra de CPIV (V660). Em relação ao CDV, 95,9% das amostras de soros foram negativas para anticorpos neutralizantes contra a amostra Snyder Hill e 90,7% soronegativas para a amostra Rockborn. Entre os soropositivos (n=20; 11,6%), somente três deles apresentaram anticorpos neutralizantes frente às duas amostras de CDV testadas, indicando pouca reatividade cruzada entre as mesmas. Quanto ao CPIV, a prevalência de anticorpos neutralizantes encontrada frente à amostra V660 foi de 51,4%. Esses achados indicam que a maioria dos cães examinados não teve contato prévio com o CDV, seja por infecção natural ou por imunização prévia. O CPIV, porém, parece estar amplamente difundido na população canina examinada, provavelmente por exposição natural ao vírus.In this report a serological survey was carried out in search for antibodies to canine distemper virus (CDV) and canine parainfluenza virus (CPIV) in 173 sera from dogs withdraw in kennels of the municipalities of Novo Hamburgo (n=82) and Porto Alegre (n=91), RS, Brazil. Neutralizing antibodies were evaluated against two CDV strains used for vaccine production (Rockborn and Snyder Hill) as well as one strain of CPIV (V660). Search for anti-CDV neutralizing antibodies revealed that 95.9% of sera were negative for antibodies to CDV Snyder Hill and 90.7% were negative for antibodies to CDV Rockborn. Among the positive sera (n=20; 11.6 %) only three of those had neutralizing antibodies to both CDV strains, indicating a low degree of cross reactivity between those. As regards CPIV, neutralizing antibodies to V660 were detected in 51.4% of sera. These findings suggest that the majority of the dogs from the populations examined in the present study had not previous contact with CDV, either by natural infection or by previous immunization. CPIV, on its turn, seem to be widespread within these populations, most likely by natural exposure to the virus.

SUMMARY: Infectious Bursal Disease is caused by a virus of the Birnaviridae family, belonging to the genus Avibirnavirus, which continues to represent a challenge for poultry production worldwide. In South America, genogroup 4 viral strains (dIBDV) have previously been detected in commercial broiler flocks. The emergence of variants needs to be constantly monitored to assess the risk of outbreaks even in vaccinated animals. The aim of this study was to identify the regional prevalence of dIBDV and evaluate its impacts on immune system organs and the performance of infected flocks in Parana state, Brazil. Thirty broiler flocks were evaluated, with an average of 24,949 birds per flock, aged between 18 and 23 d. Five Bursa of Fabricius samples were collected per flock for IBDV detection and genotyping. Positive samples for dIBDV in RFLP were submitted to sequencing of a fragment of the hypervariable region of the VP2 gene. Five samples of bursa of Fabricius, thymus, spleen, cecal tonsils and bone marrow were also collected per flock for histopathological analysis. Of the 30 flocks evaluated, in 10 (33%) IBDV from genogroup 4 (dIBDV) was detected. Flocks infected by dIBDV had significantly higher Bursa of Fabricius lesions than flocks negative for dIBDV. Flocks positive for dIBDV had their performance negatively impacted, through worsening feed conversion and an increase in mortality compared to negative flocks for dIBDV. In conclusion, genogroup 4 IBDV is capable of causing productive and health losses in broilers in Paraná, Brazil. The results of this study can help to better understand the dynamics of dIBDV infection in Brazil and to direct actions in the control of the disease.

Abstract Detection of Salmonella sp. is important for the broiler chicken production chain because it is one microorganisms involved in food-borne diseases. Thus, this study performed the optimization of a technique of Loop-mediated isothermal DNA amplification (LAMP) through the 3MTM Molecular Detection Assay 2: Salmonella (MDS®), in accordance with Ordinance number 126 of the Ministry of Agriculture, for the detection of Salmonella sp. in drag swab. The methodology followed ISO 16140-2: 2016, with the analysis naturally contaminated drag swab samples collected from broiler aviaries and artificially contaminated with salmonella ATCCs. Of the 300 samples processed in protocol A (pre-enrichment tetrathionate broth (TT)), 45 were positive for Salmonella sp., 242 negative, one false-positive, and 12 false-negative, while of the 300 samples analyzed in protocol B (pre-enrichment brain-heart infusion broth (BHI)), 40 were positive, 256 negative, one false-positive, and three false-negative. The result for protocol A was a sensitivity of 79%, specificity of 99.6%, Positive Predictive Value (PPV) of 98%, and Negative Predictive Value (NPV) of 95%; and for protocol B, 93% sensitivity, 99.6% specificity, 98% PPV, and 99% NPV. Both protocols were associated with the reference method (p>0.05), concluding that the MDS® can be used for the qualitative detection of Salmonella sp.

Salmonella enterica can be carried by pigs and can reach the final product and the consumer. Thus, Salmonella reduction strategies along the swine production chain should be studied. In this sense, the objective of the study was to evaluate a subunit vaccine based on secondary antigens administered orally against natural infection in swine farms in Brazil. A field trial study was conducted to estimate the effect of the vaccination on the Salmonella spp. seroprevalence, presence in lymph nodes, and fecal content in commercial pig herds in a vertical integration system belonging to an agroindustry. Furthermore, nMPN, qPCR, and phagocytic activity were performed. There were no significant differences in seroprevalence between groups. The mMPN count of Salmonella spp. in feces was higher in vaccinated group (VG), ranging from 0 to 2.46 log mMPN/g, while in control group (CG) it ranged from 0.0 to 4 log mMPN/g, showing a significant group effect (p

ABSTRACT: On-farm culturing is a technology booming in Brazil. It is based on the microbiological diagnosis of milk samples collected from clinical cases of bovine mastitis, on the farm where the animals are handled, quickly, simply, and at an affordable cost. With this resource, after 24 h of incubation, the isolated microorganisms are classified as gram positive or gram negative, helping to make decisions regarding the therapy of the animals. Considering the relevance of the Midwestern region of Santa Catarina State in the national dairy production scenario, the objectives of the study were: 1) to promote the technical training of the farmers in three dairy farms located in Treze Tílias-SC, 2) to assist in the implementation and evaluation of on-farm culturing as technological resource viewing the reduced use of antimicrobials in herds. In addition to the rapid acceptance by the farmers and their efficient training, with the use of the technology, there was a 45-50% reduction in the use of antimicrobials in dairy herds. This result demonstrated a significant effect on animal health, and determines an important cost reduction for farmers, as presented in detail in this manuscript.

Bovine herpesvirus type 1 (BoHV-1) is recognized as a major cause of economic losses in cattle. Vaccination has been widely applied to minimize losses induced by BoHV-1 infections. We have previously reported the development of a differential BoHV-1 vaccine, based on a recombinant glycoprotein E (gE)-deleted virus (265gE-). In present paper the efficacy of such recombinant was evaluated as an inactivated vaccine. Five BoHV-1 seronegative calves were vaccinated intramuscularly on day 0 and boostered 30 days later with an inactivated, oil adjuvanted vaccine containing an antigenic mass equivalent to 10(7.0) fifty per cent cell culture infectious doses (CCID50) of 265gE-. Three calves were kept as non vaccinated controls. On day 60 post vaccination both vaccinated and controls were challenged with the virulent parental strain. No clinical signs or adverse effects were seen after or during vaccination. After challenge, 2/5 vaccinated calves showed mild clinical signs of infection, whereas all non vaccinated controls displayed intense rhinotracheitis and shed virus for longer and to higher titres than vaccinated calves. Serological responses were detected in all vaccinated animals after the second dose of vaccine, but not on control calves. Following corticosteroid administration in attempting to induce reactivation of the latent infection, no clinical signs were observed in vaccinated calves, whereas non vaccinated controls showed clinical signs of respiratory disease. In view of its immunogenicity and protective effect upon challenge with a virulent BoHV-1, the oil adjuvanted preparation with the inactivated 265gE- recombinant was shown to be suitable for use as a vaccine.O Herpesvírus bovino tipo 1 (BoHV-1) é reconhecido como um importante agente de perdas econômicas em bovinos. Vacinação tem sido amplamente empregada para minimizar as perdas conseqüentes a infecções com o BoHV-1. Reportamos previamente o desenvolvimento de uma vacina diferencial para BoHV-1, baseada em um recombinante do qual a glicoproteína gE (gE) foi deletada (265gE-). No presente trabalho foi realizada a avaliação da eficácia de tal recombinante como vacina inativada. Cinco bovinos soronegativos para BoHV-1 foram vacinadas por via intramuscular no dia 0 e revacinadas 30 dias após com uma vacina inativada com adjuvante oleoso, contendo massa antigênica equivalente a 10(7.0) doses infectantes para 50% dos cultivos celulares (DICC50) de 265gE-. Três animais foram mantidos como controles não vacinados. No dia 60 pós-vacinação, os animais vacinados e controles foram desafiados com a amostra virulenta parental. Nenhum sinal clínico ou efeito adverso foi observado após ou durante a vacinação. Após o desafio, 2 dos 5 animais vacinados apresentaram sinais leves de infecção, enquanto que todos os animais não vacinados apresentaram intensa rinotraqueíte e disseminaram vírus por mais tempo e em títulos mais elevados do que os animais vacinados. Respostas sorológicas foram detectadas em todos os animais vacinados depois da segunda dose de vacina, mas não nos animais do grupo controle. Após a administração de corticosteróide visando a reativação de infecções latentes, não foram observados sinais clínicos em nenhum dos 5 animais vacinados, enquanto os animais não vacinados apresentaram sinais leves de doença respiratória. Em vista de sua imunogenicidade e efeito protetor frente ao desafio com BoHV-1 virulento, a preparação oleosa com o recombinante 265gE- inativado foi demonstrada ser adequada para uso como vacina.

Torque teno sus virus (TTSuV), a member of the family Anelloviridae, is a single-stranded, circular DNA virus, widely distributed in swine populations. Presently, two TTSuV genogroups are recognized: Torque teno sus virus 1 (TTSuV1) and Torque teno sus virus 2 (TTSuV2). TTSuV genomes have been found in commercial vaccines for swine, enzyme preparations and other drugs containing components of porcine origin. However, no studies have been made looking for TTSuV in cell cultures. In the present study, a search for TTSuV genomes was carried out in cell culture lineages, in sera used as supplement for cell culture media as well as in trypsin used for cell disaggregation. DNA obtained from twenty-five cell lineages (ten from cultures in routine multiplication and fifteen from frozen ampoules), nine samples of sera used in cell culture media and five batches of trypsin were examined for the presence of TTSuV DNA. Fifteen cell lineages, originated from thirteen different species contained amplifiable TTSuV genomes, including an ampoule with a cell lineage frozen in 1985. Three cell lineages of swine origin were co-infected with both TTSuV1 and TTSuV2. One batch of trypsin contained two distinct TTSuV1 plus one TTSuV2 genome, suggesting that this might have been the source of contamination, as supported by phylogenetic analyses of sequenced amplicons. Samples of fetal bovine and calf sera used in cell culture media did not contain amplifiable TTSuV DNA. This is the first report on the presence of TTSuV as contaminants in cell lineages. In addition, detection of the viral genome in an ampoule frozen in 1985 provides evidence that TTSuV contamination is not a recent event. These findings highlight the risks of TTSuV contamination in cell cultures, what may be source for contamination of biological products or compromise results of studies involving in vitro multiplied cells.

Complexos Cumulus-Oócito (CCO) bovinos foram divididos em 4 grupos para avaliar o seu comportamento durante a manutenção em LFb e maturação in vitro (MIV) em TCM-199 com ou sem Hepes. CCO MIV por 24h em TCM-199 em estufa a 39°C com 5,00% de CO2 (Controle) tiveram o seu desenvolvimento comparado ao de CCO MIV em tubos repletos de TCM-HEPES (5,95 mg/mL), em banho-maria (BM) a 39ºC por 24h (Grupo 1 - BM24h), ao de CCO mantidos em líquido folicular bovino (LFb), por 6h a 30ºC seguido de maturação por 18h nas mesmas condições que o grupo Controle (Grupo 2 - LFb6C18h) e ao de CCO mantidos em LFb seguido da maturação por 18h sob as mesmas condições que o grupo 1 (Grupo 3 - LFb6BM18h). A fecundação foi realizada em FERT-TALP por 18h. Os zigotos foram cultivados em SOFaaci, sob óleo mineral, em bolsas plásticas gaseificadas. A taxa de clivagem no Grupo Controle foi superior a do Grupo 3 (P